Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switch to Maraviroc + Integrase Inhibitor

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by University of Maryland
Sponsor:
Information provided by (Responsible Party):
David Riedel, University of Maryland
ClinicalTrials.gov Identifier:
NCT01896921
First received: June 27, 2013
Last updated: November 10, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)